Not recruiting
Hepatic function abnormal
Not recruitingPhase 1 Study of REN001 Single‑Dose Pharmacokinetics in Adults with Normal, Mild, Moderate, or Severe Liver Impairment
InvestigationalNo placebo
Phase 1 Study of REN001 Single‑Dose Pharmacokinetics in Adults with Normal, Mild, Moderate, or Severe Liver Impairment
InvestigationalNo placebo
- Disease:Hepatic function abnormal
- Substances:–
Countries:
Hungary
Hungary- Participants:18–64 years · 65+ years · Healthy volunteers
- Sponsor:Reneo Pharmaceuticals Inc.
